Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Clinical trial NCT00089154 · COMPLETED

Trial details

NCT number: NCT00089154
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Noncontiguous Stage II Small Lymphocytic Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Stage III Small Lymphocytic Lymphoma Stage IV Small Lymphocytic Lymphoma

Start date: 2004-08-01
Primary completion: 2005-10-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.